ATE500247T1 - METHOD FOR PRODUCING 3-(1,3-DIHYDROIMIDAZOLE-2-THION-1-YL)-CHROMANES AND THIOCHROMANES AS A DOPAMINE BETA-HYDROXYLASE INHIBITOR - Google Patents

METHOD FOR PRODUCING 3-(1,3-DIHYDROIMIDAZOLE-2-THION-1-YL)-CHROMANES AND THIOCHROMANES AS A DOPAMINE BETA-HYDROXYLASE INHIBITOR

Info

Publication number
ATE500247T1
ATE500247T1 AT07076124T AT07076124T ATE500247T1 AT E500247 T1 ATE500247 T1 AT E500247T1 AT 07076124 T AT07076124 T AT 07076124T AT 07076124 T AT07076124 T AT 07076124T AT E500247 T1 ATE500247 T1 AT E500247T1
Authority
AT
Austria
Prior art keywords
thiochromanes
chromanes
thion
dihydroimidazole
producing
Prior art date
Application number
AT07076124T
Other languages
German (de)
Inventor
David Alexander Learmonth
Da Silva Patricio Manuel Vieira Soares
Alexander Beliaev
Original Assignee
Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Portela & Ca Sa filed Critical Portela & Ca Sa
Application granted granted Critical
Publication of ATE500247T1 publication Critical patent/ATE500247T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07076124T 2002-10-11 2003-10-10 METHOD FOR PRODUCING 3-(1,3-DIHYDROIMIDAZOLE-2-THION-1-YL)-CHROMANES AND THIOCHROMANES AS A DOPAMINE BETA-HYDROXYLASE INHIBITOR ATE500247T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0223719A GB2393958A (en) 2002-10-11 2002-10-11 Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
GB0224306A GB2394223B (en) 2002-10-11 2002-10-18 Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation

Publications (1)

Publication Number Publication Date
ATE500247T1 true ATE500247T1 (en) 2011-03-15

Family

ID=9945777

Family Applications (5)

Application Number Title Priority Date Filing Date
AT03256420T ATE403652T1 (en) 2002-10-11 2003-10-10 IMIDAZOLE DERIVATIVES AND THEIR USE AS PERIPHERAL-SELECTIVE INHIBITORS OF DOPAMINE BETA-HYDROXYLASES
AT07076125T ATE505465T1 (en) 2002-10-11 2003-10-10 CHROMAN- AND THIOCHROMAN-3-YL-1,3-DIHYDROIMIDAZOLE AS INHIBITORS OF DOPAMINE BETA-HYDROXYLASE AND METHOD FOR THE PRODUCTION THEREOF
AT07076124T ATE500247T1 (en) 2002-10-11 2003-10-10 METHOD FOR PRODUCING 3-(1,3-DIHYDROIMIDAZOLE-2-THION-1-YL)-CHROMANES AND THIOCHROMANES AS A DOPAMINE BETA-HYDROXYLASE INHIBITOR
AT07076122T ATE500248T1 (en) 2002-10-11 2003-10-10 SILYL-PROTECTED HYDROXYMETHYL-CARBAMOYLALKYL KETONES AS INTERMEDIATE IN THE PRODUCTION OF DOPAMINE BETA-HYDROXYLASE INHIBITORS
AT07076123T ATE550335T1 (en) 2002-10-11 2003-10-10 3,4-DIHYDRO-3-AMINO-2H-1-BENZOPYRAN AND - BENZOTHIOPYRAN DERIVATIVES AS DOPAMINE BETA-HYDROXYLASE INHIBITORS AND METHOD FOR THE PRODUCTION THEREOF

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT03256420T ATE403652T1 (en) 2002-10-11 2003-10-10 IMIDAZOLE DERIVATIVES AND THEIR USE AS PERIPHERAL-SELECTIVE INHIBITORS OF DOPAMINE BETA-HYDROXYLASES
AT07076125T ATE505465T1 (en) 2002-10-11 2003-10-10 CHROMAN- AND THIOCHROMAN-3-YL-1,3-DIHYDROIMIDAZOLE AS INHIBITORS OF DOPAMINE BETA-HYDROXYLASE AND METHOD FOR THE PRODUCTION THEREOF

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT07076122T ATE500248T1 (en) 2002-10-11 2003-10-10 SILYL-PROTECTED HYDROXYMETHYL-CARBAMOYLALKYL KETONES AS INTERMEDIATE IN THE PRODUCTION OF DOPAMINE BETA-HYDROXYLASE INHIBITORS
AT07076123T ATE550335T1 (en) 2002-10-11 2003-10-10 3,4-DIHYDRO-3-AMINO-2H-1-BENZOPYRAN AND - BENZOTHIOPYRAN DERIVATIVES AS DOPAMINE BETA-HYDROXYLASE INHIBITORS AND METHOD FOR THE PRODUCTION THEREOF

Country Status (11)

Country Link
KR (1) KR101350741B1 (en)
CN (1) CN100393715C (en)
AR (2) AR041589A1 (en)
AT (5) ATE403652T1 (en)
CY (2) CY1108452T1 (en)
DE (4) DE60322642D1 (en)
DK (2) DK1408038T3 (en)
ES (5) ES2384118T3 (en)
GB (2) GB2393958A (en)
HK (1) HK1116188A1 (en)
SI (2) SI1908760T1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
JP6161538B2 (en) * 2010-12-22 2017-07-12 バイアル−ポルテラ アンド シーエー，エス．エー． Crystal form and manufacturing method thereof
GB201316410D0 (en) * 2013-09-13 2013-10-30 Bial Portela & Ca Sa Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82401A0 (en) * 1986-05-06 1987-11-30 Merrell Dow Pharma Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them
US4868210A (en) 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
DE69531102T2 (en) * 1994-04-26 2004-04-29 Roche Palo Alto Llc, Palo Alto BENZOCYCLOHEXYLIMIDAZOLTHION DERIVATIVES

Also Published As

Publication number Publication date
CN1726211A (en) 2006-01-25
CY1108452T1 (en) 2014-04-09
KR20120038014A (en) 2012-04-20
SI1908760T1 (en) 2011-05-31
GB2394223B (en) 2007-05-16
ES2364919T3 (en) 2011-09-16
KR101350741B1 (en) 2014-01-10
GB0223719D0 (en) 2002-11-20
ATE505465T1 (en) 2011-04-15
GB0224306D0 (en) 2002-11-27
DE60322642D1 (en) 2008-09-18
HK1116188A1 (en) 2008-12-19
GB2394223A (en) 2004-04-21
GB2393958A (en) 2004-04-14
ATE403652T1 (en) 2008-08-15
SI1408038T1 (en) 2008-10-31
DK1908760T3 (en) 2011-07-25
ES2309279T3 (en) 2008-12-16
AR041589A1 (en) 2005-05-26
ES2361938T3 (en) 2011-06-24
DE60336276D1 (en) 2011-04-14
AR095674A2 (en) 2015-11-04
ATE500248T1 (en) 2011-03-15
DK1408038T3 (en) 2008-11-24
CY1112457T1 (en) 2015-12-09
ES2384118T3 (en) 2012-06-29
CN100393715C (en) 2008-06-11
ES2361939T3 (en) 2011-06-24
ATE550335T1 (en) 2012-04-15
DE60336772D1 (en) 2011-05-26
DE60336275D1 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
ATE502058T1 (en) METHOD FOR PRODUCING 1,2-DICHLOROETHANE
DE50107437D1 (en) METHOD FOR PRODUCING POLYACRYLATES
ATE302191T1 (en) METHOD FOR PRODUCING 7-SUBSTITUTED -3-QUINOLINE AND 3-QUINOLE-4-ONE CARBONITRILES
ATE376997T1 (en) METHOD FOR PRODUCING 1,4-DIPHENYLAZETIDINONE DERIVATIVES
DE50302301D1 (en) METHOD FOR PRODUCING A FORM PART
ATE396180T1 (en) METHOD FOR PRODUCING 2,6-DIAMINO-4,5,6,7-TETRAHYDROBENZOTHIAZOLE
ATE414058T1 (en) METHOD FOR PRODUCING A SULFINYL-ACETAMIDE
ATE374463T1 (en) METHOD FOR PRODUCING OXAZOLIDINONES
ATE337270T1 (en) METHOD FOR PRODUCING IRON OXIDES
DE60313797D1 (en) Semiconductor light-emitting device and method for its production
DE60323994D1 (en) PROCESS FOR PREPARING 2-CHLORO-1,1,1,2,3,3,3-HEPTAFLUORPROPAN, HEXAFLUORPROPEN AND 1,1,1,2,3,3,3-HEPTAFLUORPROPANE
DE60304119D1 (en) Process for producing thin-walled similar lattice structures
ATE430140T1 (en) METHOD FOR PRODUCING AL1,4,5Ü-OXADIAZEPINE DERIVATIVES
DE60310023D1 (en) Method for the fusion-free production of a welding rod
ATE456569T1 (en) METHOD FOR PRODUCING 6-ALKYLIDE PENEM DERIVATIVES
DE60336726D1 (en) HAFNIUM SILICIDE TARGET AND METHOD FOR THE PRODUCTION THEREOF
ATE399764T1 (en) METHOD FOR PRODUCING BISEPOXIDES AND DITHIOLES
ATE553103T1 (en) METHOD FOR PRODUCING (S)-PANTOPRAZOLE
ATE548348T1 (en) METHOD FOR PRODUCING THE R,R (OR S,S) CONFIGURATED GLYCOPYRRONIUM STEREOISOMER
ATE441662T1 (en) METHOD FOR PRODUCING ECHINOCANDINE DERIVATIVES
ATE453619T1 (en) METHOD FOR PRODUCING HYDROPEROXIDES
ATE328010T1 (en) METHOD FOR PRODUCING POLYISOBUTENE
ATE424892T1 (en) METHOD FOR PRODUCING DERIVATIVES OF 4A,5, 9,10,11,12-HEXAHYDROBENZOFURO Ä3A,3,2ÜÄ 2 U-BENZAZEPINE
ATE402138T1 (en) METHOD FOR PRODUCING 2-AMINOINDANDERIVATES
ATE500247T1 (en) METHOD FOR PRODUCING 3-(1,3-DIHYDROIMIDAZOLE-2-THION-1-YL)-CHROMANES AND THIOCHROMANES AS A DOPAMINE BETA-HYDROXYLASE INHIBITOR

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties